Literature DB >> 11427611

Utility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide class compounds.

S P Hawser1, C Jessup, J Vitullo, M A Ghannoum.   

Abstract

The susceptibility of Aspergillus fumigatus to mulundocandin, an echinocandin-like compound, and other antifungal agents was assessed by the National Committee for Clinical Laboratory Standards (NCCLS) M38-P method, a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT)-based colorimetric assay, and determination of morphologic alterations by microscopy. In contrast to the NCCLS M38-P method, which does not predict the activity in vivo, the XTT-based assay showed that A. fumigatus is susceptible to mulundocandin. Thus, the XTT-based assay might be useful for determination of the susceptibilities of molds to echinocandins. Further evaluation is warranted.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427611      PMCID: PMC88227          DOI: 10.1128/JCM.39.7.2738-2741.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents.

Authors:  S P Hawser; H Norris; C J Jessup; M A Ghannoum
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

2.  Mulundocandin, a new lipopeptide antibiotic. I. Taxonomy, fermentation, isolation and characterization.

Authors:  K Roy; T Mukhopadhyay; G C Reddy; K R Desikan; B N Ganguli
Journal:  J Antibiot (Tokyo)       Date:  1987-03       Impact factor: 2.649

3.  Mulundocandin, a new lipopeptide antibiotic. II. Structure elucidation.

Authors:  T Mukhopadhyay; B N Ganguli; H W Fehlhaber; H Kogler; L Vertesy
Journal:  J Antibiot (Tokyo)       Date:  1987-03       Impact factor: 2.649

Review 4.  Lipopeptide inhibitors of fungal glucan synthase.

Authors:  M B Kurtz; C M Douglas
Journal:  J Med Vet Mycol       Date:  1997 Mar-Apr

Review 5.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

6.  Comparison of a photometric method with standardized methods of antifungal susceptibility testing of yeasts.

Authors:  C J Clancy; M H Nguyen
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

7.  Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests.

Authors:  B Jahn; A Stüben; S Bhakdi
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

8.  Evaluation of the E test system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole.

Authors:  A L Colombo; F Barchiesi; D A McGough; A W Fothergill; M G Rinaldi
Journal:  J Antimicrob Chemother       Date:  1995-07       Impact factor: 5.790

9.  Innovative endpoint determination system for antifungal susceptibility testing of yeasts.

Authors:  R Tellier; M Krajden; G A Grigoriew; I Campbell
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

10.  Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.

Authors:  S Hawser
Journal:  J Med Vet Mycol       Date:  1996 Mar-Apr
View more
  8 in total

Review 1.  Mechanisms of fungal resistance: an overview.

Authors:  Maher M Balkis; Steven D Leidich; Pranab K Mukherjee; Mahmoud A Ghannoum
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates.

Authors:  Sevtap Arikan; Victor Paetznick; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

Review 3.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

4.  Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.

Authors:  Joseph Meletiadis; Maria Siopi; Lamprini Kanioura; Karin Meinike Jørgensen; David S Perlin; Johan W Mouton; Maiken Cavling Arendrup
Journal:  J Antimicrob Chemother       Date:  2019-08-01       Impact factor: 5.790

5.  Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa.

Authors:  Michael M Tunney; Gordon Ramage; Tyler R Field; Thomas F Moriarty; Douglas G Storey
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

6.  Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.

Authors:  Atef S Shehata; Pranab K Mukherjee; Mahmoud A Ghannoum
Journal:  J Clin Microbiol       Date:  2008-10-01       Impact factor: 5.948

7.  In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.

Authors:  Abdalla O A Ahmed; Wendy W J van de Sande; Wim van Vianen; Alex van Belkum; Ahmed H Fahal; Henri A Verbrugh; Irma A J M Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

8.  A quantitative real-time RT-PCR assay for mature C. albicans biofilms.

Authors:  Zhihong Xie; Angela Thompson; Helena Kashleva; Anna Dongari-Bagtzoglou
Journal:  BMC Microbiol       Date:  2011-05-06       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.